IGE THERAPEUTICS, INC.
Biotech · Private
Therapeutic vaccine targeting IgE using conformationally constrained IgE-binding epitopes fused to immunogenic protein scaffolds, administered transcutaneously with imiquimod adjuvant
igetherapeutics.com →- Grants
- $8.1M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 1
- 0 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · CTL for supertype natural IgE cytotoxic peptide (nECP) to guard against allergic asthma | $2,258,938 | |
| Federal grant | Department of Health and Human Services · Phase II · Broadly neutralizing(BN) pan-IgE supersite vaccine for allergic asthma | $2,609,527 | |
| Federal grant | Department of Health and Human Services · Phase II · CTL for supertype natural IgE cytotoxic peptide (nECP) to guard against allergic asthma | $856,276 | |
| Federal grant | Department of Health and Human Services · Phase II · Broadly neutralizing(BN) pan-IgE supersite vaccine for allergic asthma | $813,544 | |
| Federal grant | Department of Health and Human Services · Phase II · CTL for supertype natural IgE cytotoxic peptide (nECP) to guard against allergic asthma | $549,186 | |
| Federal grant | Department of Health and Human Services · Phase II · Broadly neutralizing(BN) pan-IgE supersite vaccine for allergic asthma | $982,439 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2693 | STEMMED, LTD | — | — |
| 2694 | Sangamo Therapeutics | — | — |
| 2695 | ARMA BIO, INC. | — | — |
| 2696 | IGE THERAPEUTICS, INC. | — | — |
| 2697 | SUDHIN BIOPHARMA COMPANY | — | — |
| 2698 | MC1R VENTURES LLC | — | — |
| 2699 | SpinCeutica, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Immunoglobulin E Vaccines And Methods Of Use Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.